Lixte Biotechnology Stock Forecast, Price & News

Lixte Biotechnology (NASDAQ:LIXT) Frequently Asked Questions

What stocks does MarketBeat like better than Lixte Biotechnology?

Wall Street analysts have given Lixte Biotechnology a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Lixte Biotechnology wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Lixte Biotechnology?

Lixte Biotechnology saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 48,400 shares, an increase of 25.4% from the September 15th total of 38,600 shares. Based on an average trading volume of 382,200 shares, the short-interest ratio is currently 0.1 days. Approximately 0.9% of the company's stock are short sold.
View Lixte Biotechnology's Short Interest.

When is Lixte Biotechnology's next earnings date?

Lixte Biotechnology is scheduled to release its next quarterly earnings announcement on Tuesday, November 9th 2021.
View our earnings forecast for Lixte Biotechnology.

How were Lixte Biotechnology's earnings last quarter?

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) released its earnings results on Tuesday, August, 10th. The company reported ($0.13) earnings per share for the quarter.
View Lixte Biotechnology's earnings history.

How has Lixte Biotechnology's stock been impacted by COVID-19 (Coronavirus)?

Lixte Biotechnology's stock was trading at $0.89 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LIXT stock has increased by 110.1% and is now trading at $1.87.
View which stocks have been most impacted by COVID-19.

Who are Lixte Biotechnology's key executives?

Lixte Biotechnology's management team includes the following people:

• John S. Kovach, Chairman, President & Chief Executive Officer
• Robert N. Weingarten, Chief Financial Officer & Vice President
• James S. Miser, Chief Medical Officer
• Eric J. Forman, Chief Administrative Officer

Who are some of Lixte Biotechnology's key competitors?

Some companies that are related to Lixte Biotechnology include Xynomic Pharmaceuticals (XYNO), Ainos (AIMD), GlycoMimetics (GLYC), Opiant Pharmaceuticals (OPNT), Iterum Therapeutics (ITRM), Lipocine (LPCN), Palatin Technologies (PTN), Tempest Therapeutics (TPST), IMARA (IMRA), Jaguar Health (JAGX), Concert Pharmaceuticals (CNCE), Metacrine (MTCR), Abeona Therapeutics (ABEO), Neptune Wellness Solutions (NEPT) and Cocrystal Pharma (COCP).
View all of LIXT's competitors.

When did Lixte Biotechnology IPO?

(LIXT) raised $7 million in an initial public offering (IPO) on Wednesday, November 25th 2020. The company issued 1,500,000 shares at $4.75 per share. WestPark Capital and WallachBeth Capital acted as the underwriters for the IPO.

What is Lixte Biotechnology's stock symbol?

Lixte Biotechnology trades on the NASDAQ under the ticker symbol "LIXT."

How do I buy shares of Lixte Biotechnology?

Shares of LIXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lixte Biotechnology's stock price today?

One share of LIXT stock can currently be purchased for approximately $1.87.

How much money does Lixte Biotechnology make?

Lixte Biotechnology has a market capitalization of $25.71 million.

How many employees does Lixte Biotechnology have?

Lixte Biotechnology employs 4 workers across the globe.

What is Lixte Biotechnology's official website?

The official website for Lixte Biotechnology is www.lixte.com.

Where are Lixte Biotechnology's headquarters?

Lixte Biotechnology is headquartered at 248 ROUTE 25A NO. 2, EAST SETAUKET NY, 11733.

How can I contact Lixte Biotechnology?

Lixte Biotechnology's mailing address is 248 ROUTE 25A NO. 2, EAST SETAUKET NY, 11733. The company can be reached via phone at (631) 830-7092 or via email at [email protected].